Core Insights - Arquitos Capital Partners reported an impressive 82.1% net return in 2025, significantly outperforming the Russell 2000's 12.8% gain, indicating strong fund performance amidst selective market conditions [1] - The fund's success was attributed to company-specific factors and a concentrated investment approach, focusing on established, cash-generating businesses while navigating volatility in mid- and small-cap equities [1] Company Highlights - Liquidia Corporation (NASDAQ:LQDA) was identified as the largest contributor to Arquitos Capital's performance in 2025, with shares increasing from $11.76 to $34.49 over the year [3] - Liquidia Corporation specializes in developing therapies for rare cardiopulmonary diseases, utilizing a proprietary drug delivery technology platform [2] - The stock of Liquidia Corporation had a one-month return of 5.56%, with a market capitalization of approximately $3.483 billion as of February 13, 2026 [2]